SC-236

CAS No. 170569-86-5

SC-236 ( SC236;SC58236 )

Catalog No. M12605 CAS No. 170569-86-5

SC-236 (SC58236) is a potent, selective, orally active inhibitor of COX-2 with IC50 of 10 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 61 Get Quote
10MG 91 Get Quote
25MG 186 Get Quote
50MG 332 Get Quote
100MG 494 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SC-236
  • Note
    Research use only, not for human use.
  • Brief Description
    SC-236 (SC58236) is a potent, selective, orally active inhibitor of COX-2 with IC50 of 10 nM.
  • Description
    SC-236 (SC58236) is a potent, selective, orally active inhibitor of COX-2 with IC50 of 10 nM; displays >1,700-fold selectivity over COX-1 (IC50=17.8 uM); exhibits anti-inflammatory properties and potent antimetastatic activity both in vitro and in vivo.
  • Synonyms
    SC236;SC58236
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    170569-86-5
  • Formula Weight
    401.80
  • Molecular Formula
    C16H11ClF3N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=S(C1=CC=C(N2N=C(C(F)(F)F)C=C2C3=CC=C(Cl)C=C3)C=C1)(N)=O
  • Chemical Name
    4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Penning TD, et al. J Med Chem. 1997 Apr 25;40(9):1347-65.
2. Lee A, et al. Cancer Res. 2006 Apr 15;66(8):4378-84.
3. Roche-Nagle G, et al. Br J Cancer. 2004 Jul 19;91(2):359-65.
molnova catalog
related products
  • Imrecoxib

    Imrecoxib is a novel and selective cyclooxygenase 2 (COX-2) inhibitor (IC50: 18 nM).

  • Fosfosal

    Fosfosal is used as anti-inflammatory agent with anti-bacterial effect.

  • Seratrodast

    Seratrodast (INN) is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist used primarily in the treatment of asthma.